| 293d740b-375e-4e53-8d1a-e68d2d803983 | SIROLIMO 1 MG/ML SOL ORAL (FR) 60 ML GRUPO 1.A | BR0268152E | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 2315d35a-ef7f-4a48-b9b8-832ba7b9fab9 | PAMIDRONATO 90 MG PÓ LIOF INJ (FR-AMP) GRUPO 2 | BR0273258E | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 2c03c669-acb3-489e-9df7-8d06bd9e1f99 | PANCRELIPASE 12.000 UI CAP GRUPO 1.B | BR0266715E | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| eeb2896d-552a-4f5e-8a73-6a79d9194ef6 | PANCRELIPASE 4.500 UI CAP GRUPO 1.B | BR0266714E | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 6f0861ea-1850-4be0-89a7-37b81118cec6 | OCTREOTIDA 0,5 MG/ML SOL INJ (AMP) GRUPO 1.B | BR0305726E | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| fb15c651-4d31-4bf9-9ec8-cf87e65a764d | BECLOMETASONA 400 MCG CAP INAL GRUPO 2 | BR0267907E | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 7be15892-fbfa-48fd-a479-98ad49ab5366 | BECLOMETASONA 250 MCG SPRAY (FR DE 200 DOSES) GRUPO 2 | BR0267590E | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 27a77604-68ff-4946-9228-d9235fbaf6cd | PANCRELIPASE 18.000 UI CAP GRUPO 1.B | BR0266716E | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 7b715154-a99b-4db1-bb6c-6d7f806bd8f8 | SALBUTAMOL 100 MCG AER BUCAL (FR DE 200 DOSES) GRUPO 2 | BR0294887E | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| bf1f8cbf-6250-4e3b-9cf0-9193e26b83f3 | BECLOMETASONA 200 MCG CAP INAL (FR DE 100 DOSES) GRUPO 2 | BR0267587E | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 09be9cd4-db9b-4057-9c35-8d6557df83dc | BECLOMETASONA 400 MCG PÓ INAL (FR DE 100 DOSES) GRUPO 2 | BR0267589E | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| c014e2ca-5f93-4094-8725-6159786c7f2a | PANCRELIPASE 20.000 UI CAP GRUPO 1.B | BR0266713E | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| a3e71e64-3ab5-447a-b6a2-57682defa829 | BOCEPREVIR 200 MG CAP GRUPO 1.A | BR0404790E | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| d73ec5bb-657c-454b-9172-888c417f17e9 | BECLOMETASONA 200 MCG CAP INAL GRUPO 2 | BR0267586E | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 805cfa8f-674b-4ac0-813b-a2d6411ef9cd | HIDRÓXIDO DE ALUMÍNIO 61,5 MG SUSP ORAL (FR) 100 ML GRUPO 2 | BR0340783-1E | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 970b52f7-891f-4fa7-aa83-2e5546edb608 | ACETAZOLAMIDA 250 MG COMP GRUPO 2 | BR0278283U0042E | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 742e9ad8-7bef-495e-a064-6ed2e28149b5 | TELAPREVIR 375 MG COMP GRUPO 1.A | BR0412470E | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 453547b9-ac5a-4240-8049-5a701ee795c2 | SIMEPREVIR 150 MG CAP GRUPO 1.A | BR0431752U0041 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| b9e13daf-a079-4b90-853e-494bcf726c6b | BROMETO DE UMECLIDÍNIO + TRIFENATATO DE VILANTEROL 62,5 + 25 MCG PÓ INAL (FR DE 30 DOSES) GRUPO 1.B | BR0437993U0269 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 37f5b73e-37c7-408d-8ec3-f7351d05e6d1 | BROMETO DE TIOTRÓPIO MONOIDRATADO + CLORIDRATO DE OLODATEROL 2,5 + 2,5 MCG SOLUÇÃO PARA INALAÇÃO GRUPO 1.B | BR0466366U0109 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 61e0d066-16b7-4b3a-a325-0ef7c779a63d | ADALIMUMABE (BIOSSIMILAR A) 40 MG SOL INJ (SER PREENC) GRUPO 1.A | BR0290058U0135B0127 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 059dd767-0410-4f79-8617-762d58f7e7a1 | ADALIMUMABE (BIOSSIMILAR B) 40 MG SOL INJ (SER PREENC) GRUPO 1.A | BR0290058U0135B0135 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 8cc50955-011f-45d9-a74c-19bd006639f1 | SELEXIPAGUE 1000 MCG COMPRIMIDO GRUPO 1.B | BR0465391U0042 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 06da873a-f816-4725-8b6f-0a124c8b0500 | IVACAFTOR 150 MG COMP REV GRUPO 1.A | BR0448290U0042 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 4887d6c8-d4c8-41e2-9136-3c4434280577 | RITUXIMABE (BIOSSIMILAR B CELLTRION/TRUXIMA/RUXIENCE®) 100 MG SOL INJ (FR-AMP) 10 ML GRUPO 1.A | BR0268520U0118B0074 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 806d7260-9989-4aae-8de7-8652b96db989 | SELEXIPAGUE 200 MCG COMPRIMIDO GRUPO 1.B | BR0465388U0042 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 068a349e-c5da-4ed1-bfdb-001592dad31b | RISDIPLAM 0,75 MG/ML PÓ PARA SOLUÇÃO 80 ML GRUPO 1.A | BR0478939U0115 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 818d6019-8c11-40bd-bdf2-071016a8e364 | SELEXIPAGUE 200 MCG COMPRIMIDO TITULAÇÃO DE DOSE GRUPO 1.B | BR0465388U0042T0111 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 9f174a4f-2d3e-47b3-b480-307617b77d58 | RITUXIMABE (BIOSSIMILAR B CELLTRION/TRUXIMA/RUXIENCE®) 500 MG SOL INJ (FR-AMP) 50 ML GRUPO 1.A | BR0268520U0118B0040 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| d681842e-8cd5-497f-8fa1-124c29900127 | SELEXIPAGUE 1200 MCG COMPRIMIDO GRUPO 1.B | BR0465389U0042 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 6a202107-e32b-4ebd-b17e-6136fba3195f | SELEXIPAGUE 800 MCG COMPRIMIDO GRUPO 1.B | BR0465387U0042 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| d5944fbf-bbe6-41cd-b039-a5739e92cd4d | ELEXACAFTOR ASSOCIADO AO TEZACAFTOR E IVACAFTOR 50 + 25 + 37,5 + 75 MG COMPRIMIDO GRUPO 1.A | BR0601654U0042 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 62ed31e8-54ec-4ee9-8f13-5f1679ec868c | ADALIMUMABE 40 MG SOL INJ (FR-AMP) GRUPO 1.A | BR0290058U0118 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| e091e0a0-5a10-4a2d-a49b-ef1f6320cca2 | CLADRIBINA 10 MG COMPRIMIDO GRUPO 1.A | BR0483113U0042 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 49ef307a-556e-44f4-8ae1-327a79664908 | SELEXIPAGUE 600 MCG COMPRIMIDO GRUPO 1.B | BR0465386U0042 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 161c98c6-8825-4927-880b-55b31e8e4650 | BARICITINIBE 2 MG COMPRIMIDO GRUPO 1.A | BR0473091U0042 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 29266fd4-52e5-4bd4-80e2-7d5907f9db7c | LEVETIRACETAM 1000 MG COMPRIMIDO GRUPO 1.A | BR0429678U0042 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| c728d1db-4396-4e4d-852a-32e661800102 | ECULIZUMABE 10 MG/ML SOL INJ (FR) 30 ML GRUPO 1.A | BR0368694U0097 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 02b52b55-dcb1-47ca-8d4e-7c7084d0a9f8 | ROMOSOZUMABE 90 MG/ML SOLUÇÃO INJETÁVEL (POR SERINGA PREENCHIDA) 1,17 ML GRUPO 1.A | BR0480015U0135 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 4ffb5a98-8e2e-4eee-8a2a-3932381f1851 | RISANQUIZUMABE 150 MG/ML SOLUÇÃO INJETÁVEL C/ SISTEMA DE APLICA GRUPO 1.A | BR0625297U0234 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| f11ca65a-0aa6-4cf9-8c3a-1b5443b8300e | OMBITASVIR/VERUPREVIR/RITONAVIR + DASABUVIR 12,5/75/50 MG + 250 MG CARTELA (04 COMP REV) GRUPO 1.A | BR0435700U0032 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 7967180a-f451-4f2c-9545-fd007121f8e0 | ADALIMUMABE (BIOSSIMILAR C) 40 MG SOL INJ (SER PREENC) GRUPO 1.A | BR0290058U0135B143 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| cce1bff4-9698-4467-9636-791dfc199e57 | LEVETIRACETAM 500 MG COMPRIMIDO GRUPO 1.A | BR0285966U0042 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| f1fcf5f4-7512-4546-b227-21e59a7a251b | ALFAVESTRONIDASE 2 MG/ML SOLUÇÃO INJETÁVEL 5 ML GRUPO 1.A | BR0451638U0106 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| f8b13285-e31b-4958-9932-62a1b9856677 | SELEXIPAGUE 1600 MCG COMPRIMIDO GRUPO 1.B | BR0464164U0042 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 248d79c4-133d-4c30-bdb0-87f59f1fa54f | SELEXIPAGUE 400 MCG COMPRIMIDO GRUPO 1.B | BR0465385U0042 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 3f8c210e-9842-47dc-9555-f7389d9660e9 | INSULINA ANÁLOGA DE AÇÃO RÁPIDA 100 UI/ML TUBETE COM SISTEMA DE APLICAÇÃO DESCARTÁVEL 3 ML GRUPO 1.A | BR0440255U01371A | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| a60cbfbe-840b-4ae5-ada5-ee367d652d32 | MEPOLIZUMABE 100 MG/ML SOLUÇÃO INJETÁVEL GRUPO 1.B | BR0457885U0118 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| 991df1c5-20cf-49d6-aa74-3aea12a8352a | ALENTUZUMABE 10 MG/ML SOL INJ (FR-AMP) 1,2 ML GRUPO 1.A | BR0388865U0118 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |
| eb60cc43-3562-4617-80c3-e8ec406e1806 | DIPROPIONATO DE FUROATO DE FLUTICASONA + BROMETO DE UMECLIDÍNIO + TRIFENATATO DE VILANTEROL 100+62,5+25 MCG PÓ PARA INALAÇÃO ORAL 30 DOSES GRUPO 1.B | BR0477861U0269 | E | 1 | 2026-06-22T16:09:00.934126+00:00 | 2026-06-22T16:09:00.934126+00:00 |